🔎 Trials Near Me

Početna › Upalna bolest crijeva › Massachusetts

Kliničke studije za Upalna bolest crijeva u državi Massachusetts

15 studija za Upalna bolest crijeva traži sudionike na lokacijama u državi Massachusetts.

Gradovi u državi Massachusetts

Službeni tekst studije (engleski)

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

  • Massachusetts General Hospital, Boston
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07033208

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 003, Boston
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07012395

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Boston Childrens Hospital, Boston
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT05923073

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Boston Children's Hospital, Boston
  • Massachusetts General Hospital, Waltham
U tijeku regrutacijaFaza 3
Od 2 do 19 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Boston Children's Hospital, Boston
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 24. kol 2026. · NCT05509777

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • Brigham and Women's Hospital, Boston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT07237516

Low Dose IL-2 for the Treatment of Crohn's Disease

  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
U tijeku regrutacijaFaza 1/2
Od 12 do 80 godina · Oba spola · Ažurirano 3. kol 2026. · NCT04263831

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Boston Children's Hospital, Boston
U tijeku regrutacijaFaza 4
Od 6 do 17 godina · Oba spola · Ažurirano 27. svi 2026. · NCT05781152

Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility

  • Massachusetts General Hospital, Boston
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 14 godina i više · Oba spola · Ažurirano 30. sij 2026. · NCT05332639

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

  • Massachusetts General Hospital, Boston
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 16. pro 2025. · NCT07219537

Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis

  • Massachusetts General Hospital, Boston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 6. stu 2025. · NCT07168499

Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • Boston Children's Hospital, Boston
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 13 do 20 godina · Oba spola · Ažurirano 30. lis 2025. · NCT04508088

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

  • Boston Children's Hospital, Boston
U tijeku regrutacijaOpažajna studija
Od 5 do 25 godina · Oba spola · Ažurirano 3. ožu 2025. · NCT04331639

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

  • Massachusetts General Hospital, Boston
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 14 godina i više · Oba spola · Ažurirano 20. pro 2024. · NCT06655415

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.